• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Amphastar Pharmaceuticals, Inc. - Common Stock (NQ:AMPH)

20.25 -1.54 (-7.05%)
Streaming Delayed Price Updated: 10:35 AM EDT, Jun 29, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Amphastar Pharmaceuticals, Inc. - Common Stock

< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
News headline image
Amphastar Pharmaceuticals to Present at the Jefferies London Healthcare Conference
November 13, 2024
Via ACCESSWIRE
News headline image
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2024
November 06, 2024
Via ACCESSWIRE
News headline image
Amphastar Casts Wide Net, Hauls In Profits, Gets Rating Upgrade ↗
October 15, 2024
Amphastar hit an all-time high in August 2023 and consolidated. It could be forming the right side of a cup base that started in January. 
Via Investor's Business Daily
News headline image
JP Morgan Shows Most Interest In Teva, Organon As Specialty Pharma Sector Exhibits Signs Of Stability ↗
September 06, 2024
JP Morgan assesses the specialty pharma sector, highlighting robust fundamentals and new product excitement. Key focus on Teva, Organon, and Viatris. 
Via Benzinga
News headline image
Amphastar Pharmaceuticals to Present at the 2024 Wells Fargo Healthcare Conference
August 28, 2024
Via ACCESSWIRE
News headline image
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2024
August 07, 2024
Via ACCESSWIRE
News headline image
Why the growth investor may take a look at NASDAQ:AMPH. ↗
June 05, 2024
AMPHASTAR PHARMACEUTICALS IN (NASDAQ:AMPH) may be suited for growth investing, we'll explore why in this article. 
Via Chartmill
News headline image
Exploring NASDAQ:AMPH's growth characteristics. ↗
May 15, 2024
AMPHASTAR PHARMACEUTICALS IN (NASDAQ:AMPH) showing high EPS and FCF growth while beating expectations 
Via Chartmill
News headline image
AMPH Stock Earnings: Amphastar Pharma Beats EPS, Beats Revenue for Q2 2024 ↗
August 07, 2024
AMPH stock results show that Amphastar Pharma beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
News headline image
Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 7, 2024
July 31, 2024
Via ACCESSWIRE
News headline image
7 Biotech Stocks to Buy on the Dip: June 2024 ↗
June 24, 2024
With health being a top priority over wealth generation, these biotech stocks to buy on the dip enjoy a sound framework for speculation. 
Via InvestorPlace
News headline image
Top 2 Small Cap Healthcare Stocks to Buy Before Rate Cuts
June 18, 2024
These 2 small cap healthcare stocks could boom on a new sector breakout, Wall Street analysts see up to double-digit upside in each 
Via MarketBeat
Topics ETFs Economy
News headline image
Amphastar Announces Additional $50 Million Increase to its Share Buyback Program
June 04, 2024
Via ACCESSWIRE
News headline image
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2024
May 08, 2024
Via ACCESSWIRE
News headline image
NASDAQ:AMPH, an undervalued stock with good fundamentals. ↗
March 12, 2024
AMPHASTAR PHARMACEUTICALS IN (NASDAQ:AMPH): good value for what you're paying. 
Via Chartmill
News headline image
Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full-Year Ended December 31, 2023
February 28, 2024
Via ACCESSWIRE
News headline image
Amphastar Pharmaceuticals to Present at the Jefferies Global Healthcare Conference
June 03, 2024
Via ACCESSWIRE
News headline image
Amphastar Receives FDA Approval for Albuterol Sulfate Inhalation Aerosol
May 22, 2024
Via ACCESSWIRE
News headline image
Patent Peril: 3 Stocks at Risk From the FTC’s Drug Crusade ↗
May 16, 2024
The FTC is putting these three drug stocks at risk by trying to strip their therapies of protection from generics. 
Via InvestorPlace
Topics Intellectual Property
News headline image
Amphastar Pharmaceuticals to Present at the Bank of America Securities Health Care Conference
May 09, 2024
Via ACCESSWIRE
News headline image
AMPH Stock Earnings: Amphastar Pharma Beats EPS, Misses Revenue for Q1 2024 ↗
May 08, 2024
AMPH stock results show that Amphastar Pharma beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
Delving into NASDAQ:AMPH's Growth Prospects. ↗
February 28, 2024
Should you consider AMPHASTAR PHARMACEUTICALS IN (NASDAQ:AMPH) for growth investing? 
Via Chartmill
News headline image
Earnings Outlook For Amphastar Pharma ↗
February 27, 2024
 
Via Benzinga
News headline image
Is NASDAQ:AMPH a Fit for Growth Investing Strategies? ↗
February 14, 2024
Is AMPHASTAR PHARMACEUTICALS IN (NASDAQ:AMPH) suited for growth investing? 
Via Chartmill
News headline image
Federal Trade Commission Targets 'Junk Patent Listings' For Diabetes, Weight Loss, Asthma Drugs From Companies Like Novo Nordisk, AstraZeneca ↗
May 01, 2024
The FTC intensifies efforts against pharmaceutical patent listings, disputing junk patents for diabetes, weight loss, asthma, and COPD medications. This initiative combats tactics hindering generic... 
Via Benzinga
Topics Intellectual Property
News headline image
Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 8, 2024
April 30, 2024
Via ACCESSWIRE
News headline image
Amphastar Pharmaceuticals Interested In Potential Acquisitions In Endocrinology-Focused Companies ↗
April 10, 2024
Amphastar Pharmaceuticals discusses the future of Baqsimi at the Needham Healthcare Conference, highlighting its potential amid a growing market for glucagon products. With promising sales projections... 
Via Benzinga
News headline image
Amphastar Pharmaceuticals to Present at the 23rd Annual Needham Virtual Healthcare Conference
April 01, 2024
Via ACCESSWIRE
News headline image
Amphastar Pharmaceuticals to Present at the Barclays 26th Annual Global Healthcare Conference
March 06, 2024
Via ACCESSWIRE
News headline image
Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 28, 2024
February 20, 2024
Via ACCESSWIRE
< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap